These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 17105662)
1. Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania. Hetzel MW; Msechu JJ; Goodman C; Lengeler C; Obrist B; Kachur SP; Makemba A; Nathan R; Schulze A; Mshinda H Malar J; 2006 Nov; 5():109. PubMed ID: 17105662 [TBL] [Abstract][Full Text] [Related]
2. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug. Mubyazi GM; Gonzalez-Block MA Malar J; 2005 Oct; 4():51. PubMed ID: 16242017 [TBL] [Abstract][Full Text] [Related]
3. Insights following change in drug policy: a descriptive study for antimalarial prescription practices in children of public sector health facilities in Jharkhand state of India. Mishra N; Gupta R; Singh S; Rana R; Shahi B; Das MK; Anvikar AR; Valecha N J Vector Borne Dis; 2013 Dec; 50(4):271-7. PubMed ID: 24499849 [TBL] [Abstract][Full Text] [Related]
4. Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Goodman C; Kachur SP; Abdulla S; Mwageni E; Nyoni J; Schellenberg JA; Mills A; Bloland P Trop Med Int Health; 2004 Jun; 9(6):655-63. PubMed ID: 15189455 [TBL] [Abstract][Full Text] [Related]
5. Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective. Alba S; Hetzel MW; Goodman C; Dillip A; Liana J; Mshinda H; Lengeler C Malar J; 2010 Jun; 9():164. PubMed ID: 20550654 [TBL] [Abstract][Full Text] [Related]
6. How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy. Nsimba SE J Ethnobiol Ethnomed; 2006 Jan; 2():5. PubMed ID: 16403225 [TBL] [Abstract][Full Text] [Related]
7. Adoption of the new antimalarial drug policy in Tanzania--a cross-sectional study in the community. Eriksen J; Nsimba SE; Minzi OM; Sanga AJ; Petzold M; Gustafsson LL; Warsame MY; Tomson G Trop Med Int Health; 2005 Oct; 10(10):1038-46. PubMed ID: 16185239 [TBL] [Abstract][Full Text] [Related]
8. Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change. Basco LK; Ngane VF; Ndounga M; Same-Ekobo A; Youmba JC; Abodo RT; Soula G Am J Trop Med Hyg; 2006 Sep; 75(3):388-95. PubMed ID: 16968911 [TBL] [Abstract][Full Text] [Related]
9. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania. Tarimo DS; Malekela DA East Afr J Public Health; 2007 Apr; 4(1):43-6. PubMed ID: 17907761 [TBL] [Abstract][Full Text] [Related]
10. Poor knowledge on new malaria treatment guidelines among drug dispensers in private pharmacies in Tanzania: the need for involving the private sector in policy preparations and implementation. Minzi OM; Haule AF East Afr J Public Health; 2008 Aug; 5(2):117-21. PubMed ID: 19024421 [TBL] [Abstract][Full Text] [Related]
11. Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa. Nahum A; Erhart A; Gazard D; Agbowai C; Van Overmeir C; van Loen H; Menten J; Akogbeto M; Coosemans M; Massougbodji A; D'Alessandro U Malar J; 2007 Dec; 6():170. PubMed ID: 18154655 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of chloroquine (CQ) and sulphadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas. Mohapatra PK; Prakash A; Taison K; Negmu K; Gohain AC; Namchoom NS; Wange D; Bhattacharyya DR; Goswami BK; Borgohain BK; Mahanta J Trop Med Int Health; 2005 May; 10(5):478-83. PubMed ID: 15860095 [TBL] [Abstract][Full Text] [Related]
13. Response of falciparum malaria to different antimalarials in Myanmar. Ejov MN; Tun T; Aung S; Sein K Bull World Health Organ; 1999; 77(3):244-9. PubMed ID: 10212515 [TBL] [Abstract][Full Text] [Related]
14. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan. Kolaczinski K; Durrani N; Rahim S; Rowland M Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1081-7. PubMed ID: 17707447 [TBL] [Abstract][Full Text] [Related]
15. Vendor-to-vendor education to improve malaria treatment by private drug outlets in Bungoma District, Kenya. Tavrow P; Shabahang J; Makama S Malar J; 2003 May; 2():10. PubMed ID: 12812525 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. East African Network for Monitoring Antimalarial Treatment (EANMAT) Trop Med Int Health; 2003 Oct; 8(10):860-7. PubMed ID: 14516296 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004. Patrick Kachur S; Schulden J; Goodman CA; Kassala H; Elling BF; Khatib RA; Causer LM; Mkikima S; Abdulla S; Bloland PB Trop Med Int Health; 2006 Apr; 11(4):441-51. PubMed ID: 16553927 [TBL] [Abstract][Full Text] [Related]
18. Falciparum malaria fully cleared by amodiaquine, pyrimethamine-sulfadoxine and pyrimethamine-sulfalene in areas of chloroquine resistance in Dodoma, Tanzania. Irare SG; Lemnge MM; Mhina JI Trop Geogr Med; 1991 Oct; 43(4):352-6. PubMed ID: 1812599 [TBL] [Abstract][Full Text] [Related]
19. Comparative Study of Effectiveness and Resistance Profile of Chloroquine and Sulfadoxine-Pyrimethamine in Uncomplicated Plasmodium falciparum Malaria in Kolkata. Basu A; Saha S; Guha SK J Assoc Physicians India; 2015 May; 63(5):32-7. PubMed ID: 26591142 [TBL] [Abstract][Full Text] [Related]
20. Current clinical efficacy of chloroquine for the treatment of Plasmodium falciparum infections in urban Dar es Salaam, United Republic of Tanzania. Premji Z; Makwaya C; Minjas JN Bull World Health Organ; 1999; 77(9):740-4. PubMed ID: 10534897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]